BioSpace News Archive

Bio NC

IQVIA’s OCE Technology Platform Selected by Zambon to Establish a Global Multichannel Commercial Engagement Model for OTC Business

Italian multinational pharmaceutical company to coordinate all physical and digital activities with pharmacists using IQVIA Technologies’ end-to-end solution.

June 4, 2019
·
4 min read
Policy

Glytec Developing Novel Solution for Selection and Dosing of All Diabetes Medications

New product will be the market’s first and only to enable optimization of ALL diabetes medications, insulin and non-insulin alike.

June 4, 2019
·
6 min read
Genetown

Vertex to Present Data at ECFS Conference on Potential Impact of Early Treatment and Long-Term Treatment with CFTR Modulators on the Underlying Cause of CF

Vertex Pharmaceuticals Incorporated announced that data from six scientific abstracts from the company’s portfolio of cystic fibrosis medicines will be presented at the 42nd European Cystic Fibrosis Conference, taking place June 5-8, 2019 in Liverpool, UK.

June 4, 2019
·
16 min read
Business

Outcome Capital and Partners HealthCare Innovation Collaborate through the Innovation Fellows Program to Provide Experience in the Business of Science

The program will provide research fellows at Massachusetts General Hospital, Brigham and Women’s Hospital and McLean Hospital with exposure to the real-world intersection of business and science and an opportunity to experience the unique business challenges in the life sciences sector.

June 4, 2019
·
3 min read
Pharm Country

Universal Display Corporation to Webcast Annual Shareholders Meeting

The audio portion of the presentation will be webcast live and archived on the events page of the Company’s Investor Relations website at ir.oled.com.

June 4, 2019
·
3 min read
Deals

Global Cord Blood Corporation Announces Receipt of Preliminary Non-Binding Proposal to Acquire the Company

Cordlife will issue its ordinary shares at an issue price of SGD0.5 per ordinary share in exchange for all of the outstanding ordinary shares of the Company at US$7.50 per ordinary share.

June 4, 2019
·
4 min read
Bio NC

Allbridge Named to List of 2019 Best Employers in North Carolina

This survey and awards program was designed to identify, recognize, and honor the best employers in North Carolina, benefiting the economy, workforce, and businesses.

June 4, 2019
·
3 min read
Policy

Mesothelioma Victims Center Now Urges a US Navy Veteran with Mesothelioma to Hire Very Capable Attorneys to Assist with Their Compensation and They Recommend the Law Firm of Karst von Oiste

The Mesothelioma Victims Center is one of top branded sources in the United States for a US Navy Veteran with mesothelioma and their number one goal for people like this is the best possible financial compensation results.

June 4, 2019
·
3 min read
Policy

BioMarin Announces Approval of Vimizim® (elosulfase alfa) in China for Treatment of Morquio A Syndrome

BioMarin Pharmaceutical Inc. announced that Vimizim® has been approved by the National Medical Products Administration for the treatment of patients with mucopolysaccharidosis type IVA, also known as Morquio A syndrome.

June 4, 2019
·
9 min read
Drug Development

Dance Biopharm to Present Data from Phase 2 Clinical Trial of Dance 501 Inhaled Insulin Therapy at American Diabetes Association Meeting

This trial, conducted in patients with type 2 diabetes, compared three doses each of Dance 501 inhaled insulin and subcutaneous insulin lispro

June 4, 2019
·
2 min read